Proposal to inform European institutions regarding the regulation of conscientious objection to abortion.

Lertxundi R, Ibarrondo O, Merki-Feld GS, Rey-Novoa M, Rowlands S, Mar J.

European Journal Of Contraception And Reproductive Health Care. 2016; 21: 198-200. FI: 1,627 (Q3).

Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Ecological Study in the Basque Country, Spain (2000-2011).

Tamayo-Uria I, Altzibar JM, Mughini-Gras L, Dorronsoro M.

Copd-Journal Of Chronic Obstructive Pulmonary Disease. 2016; 13: 726-733. FI: 2,576 (Q3).

Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence.

Gimeno-Ballester, Vicente, Simón, Miguel Ángel, Trigo, Cristina, MAR MEDINA, JAVIER, San Miguel, Ramón

Expert Rev Gastroent. 2016; 10: 1289-1303. FI: 2,743 (Q3).

Cost-utility analysis of an integrated care model for multimorbid patients based on a clinical trial.

Lanzeta I, Mar J, Arrospide A.

Gaceta Sanitaria. 2016; 30: 352-358. FI: 1,768 (Q3).

Perinatal and childhood factors and risk of breast cancer subtypes in adulthood.

Lope V, García-Esquinas E, Pérez-Gómez B, Altzibar JM, Gracia-Lavedan E, Ederra M, Molina de la Torre AJ, LLorca FJ, Tardón A, Moreno V, Bayo J, Salas-Trejo D, Marcos-Gragera R, Pumarega J, Dierssen-Sotos T, Lera JP, de Miguel Medina MA, Tusquets I, Amiano P, Boldo E, Kogevinas M, Aragonés N, Castaño-Vinyals G, Pollán M.

Cancer Epidemiology. 2016; 40: 22-30. FI: 2,343 (Q2).

Prospective association of liver function biomarkers with development of hepatobiliary cancers.

Stepien M, Fedirko V, Duarte-Salles T, Ferrari P, Freisling H, Trepo E, Trichopoulou A, Bamia C, Weiderpass E, Olsen A, Tjønneland A, Overvad K, Boutron-Ruault MC, Fagherazzi G, Racine A, Kühn T, Kaaks R, Aleksandrova K, Boeing H, Lagiou P, Benetou V, Trichopoulos D, Palli D, Grioni S, Tumino R, Naccarati A, Panico S, Bueno-de-Mesquita HB, Peeters PH, Lund E, Quirós JR, Nápoles OC, Sánchez MJ, Dorronsoro M, Huerta JM, Ardanaz E, Ohlsson B, Sjöberg K, Werner M, Nystrom H, Khaw KT, Key TJ, Gunter M, Cross A, Riboli E, Romieu I, Jenab M.

Cancer Epidemiology. 2016; 40: 179-187. FI: 2,343 (Q2).

Association of diabetes and diabetes treatment with incidence of breast cancer.

García-Esquinas E, Guinó E, Castaño-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, Martín V, Moreno-Iribas C, Tardón A, Caballero FJ, Puig-Vives M, Guevara M, Villa TF, Salas D, Amiano P, Dierssen-Sotos T, Pastor-Barriuso R, Sala M, Kogevinas M, Aragonés N, Moreno V, Pollán M.

Acta Diabetologica. 2016; 53: 99-107. FI: 3,34 (Q2).

Cardiometabolic Risk Related to the Association of Hypertriglyceridemia-Low HDLc.

Millán-Núñez J, Mantilla-Morató T, Toro R, Millán-Pérez JJ, Mangas-Rojas A, Scientific Committee of Hypertriglyceridemia Registry of Spanish Society of Arte

Current Pharmaceutical Design. 2016; 22: 365-371. FI: 2,611 (Q2).

Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C.

Gimeno-Ballester V, Mar J, San Miguel R.

Expert Review Of Pharmacoeconomics & Outcomes Research. 2016; 16: 285-294. FI: 1,78 (Q2).

Social class based on occupation is associated with hospitalization for A(H1N1)pdm09 infection. Comparison between hospitalized and ambulatory cases.

Pujol J, Godoy P, Soldevila N, Castilla J, González-Candelas F, Mayoral JM, Astray J, Garcia S, Martin V, Tamames S, Delgado M, Domínguez A, CIBERESP Cases and Controls in Pandemic Influenza Working Group

Epidemiology And Infection. 2016; 144: 732-740. FI: 2,075 (Q2).